BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tarantino G, Citro V, Capone D. Nonalcoholic Fatty Liver Disease: A Challenge from Mechanisms to Therapy. J Clin Med. 2019;9. [PMID: 31861591 DOI: 10.3390/jcm9010015] [Cited by in Crossref: 37] [Cited by in F6Publishing: 50] [Article Influence: 12.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang K, Li B, Fu R, Jiang Z, Wen X, Ni Y. Bentong ginger oleoresin mitigates liver injury and modulates gut microbiota in mouse with nonalcoholic fatty liver disease induced by high‐fat diet. Journal of Food Science. [DOI: 10.1111/1750-3841.16076] [Reference Citation Analysis]
2 Liu Y, Liu L, Xing W, Sun Y. Anesthetics mediated the immunomodulatory effects via regulation of TLR signaling. Int Immunopharmacol 2021;:108357. [PMID: 34785143 DOI: 10.1016/j.intimp.2021.108357] [Reference Citation Analysis]
3 Pham Van B, Nguyen Thi Thanh H, Le Thi H, Nguyen Le Tuan A, Dang Thi Thu H, Dang Viet D. Nutritional Status and Feeding Regimen of Patients with Esophagus Cancer-A Study from Vietnam. Healthcare (Basel) 2021;9:289. [PMID: 33800823 DOI: 10.3390/healthcare9030289] [Reference Citation Analysis]
4 Yang J, Zhang H, Parhat K, Xu H, Li M, Wang X, Ran C. Molecular Imaging of Brown Adipose Tissue Mass. Int J Mol Sci 2021;22:9436. [PMID: 34502347 DOI: 10.3390/ijms22179436] [Reference Citation Analysis]
5 Gong R, Tang X, Jiang Z, Luo G, Dong C, Han X, Wang X. Serum 25(OH)D Levels Modify the Association between Triglyceride and IR: A Cross-Sectional Study. International Journal of Endocrinology 2022;2022:1-8. [DOI: 10.1155/2022/5457087] [Reference Citation Analysis]
6 Zhu Y, Xu J, Zhang X, Ke Y, Fu G, Guo Q. A low follicle-stimulating hormone level is a protective factor for non-alcoholic fatty liver disease in older men aged over 80. BMC Geriatr 2021;21:544. [PMID: 34641807 DOI: 10.1186/s12877-021-02490-6] [Reference Citation Analysis]
7 Geng Q, Zhang P, Liu X, Xue L. Effect of berberine and bicyclol on Chinese patients with non-alcoholic fatty liver disease: a retrospective study. Postgrad Med 2022. [PMID: 35382695 DOI: 10.1080/00325481.2022.2063568] [Reference Citation Analysis]
8 Wu Z, Xiao L, Wang H, Wang G. Neurogenic hypothesis of positive psychology in stress-induced depression: Adult hippocampal neurogenesis, neuroinflammation, and stress resilience. Int Immunopharmacol 2021;97:107653. [PMID: 33915495 DOI: 10.1016/j.intimp.2021.107653] [Reference Citation Analysis]
9 Agostino M, Rooney J, Herat L, Matthews J, Simonds A, Northfield SE, Hopper D, Schlaich MP, Matthews VB. TNFSF14-Derived Molecules as a Novel Treatment for Obesity and Type 2 Diabetes. Int J Mol Sci 2021;22:10647. [PMID: 34638990 DOI: 10.3390/ijms221910647] [Reference Citation Analysis]
10 Kozlova MA, Kirillov YA, Makartseva LA, Chernov I, Areshidze DA. Morphofunctional State and Circadian Rhythms of the Liver under the Influence of Chronic Alcohol Intoxication and Constant Lighting. Int J Mol Sci 2021;22:13007. [PMID: 34884810 DOI: 10.3390/ijms222313007] [Reference Citation Analysis]
11 Mahabaleshwarkar R, Liu TL, McKillop IH, Spencer M. The Association Between Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease Diagnosis Varies by Race. Metab Syndr Relat Disord 2022. [PMID: 35319282 DOI: 10.1089/met.2021.0108] [Reference Citation Analysis]
12 Yin C, Li Z, Xiang Y, Peng H, Yang P, Yuan S, Zhang X, Wu Y, Huang M, Li J. Effect of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis. Front Nutr 2021;8:709683. [PMID: 34322514 DOI: 10.3389/fnut.2021.709683] [Reference Citation Analysis]
13 Bayliss J, Ooi GJ, De Nardo W, Shah YJH, Montgomery MK, McLean C, Kemp W, Roberts SK, Brown WA, Burton PR, Watt MJ. Ectodysplasin A Is Increased in Non-Alcoholic Fatty Liver Disease, But Is Not Associated With Type 2 Diabetes. Front Endocrinol (Lausanne) 2021;12:642432. [PMID: 33746906 DOI: 10.3389/fendo.2021.642432] [Reference Citation Analysis]
14 Lin YC, Wang HY, Kuo YC, Chen MJ, Wu MS, Liu CJ, Yang HW, Shih SC, Yu LY, Ko HJ, Yeh HI, Hu KC. Gut-flora metabolites is not associated with synchronous carotid artery plaque and non-alcoholic fatty liver disease in asymptomatic adults: A STROBE-compliant article. Medicine (Baltimore) 2021;100:e27048. [PMID: 34449492 DOI: 10.1097/MD.0000000000027048] [Reference Citation Analysis]
15 Armandi A, Rosso C, Caviglia GP, Ribaldone DG, Bugianesi E. The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review. Front Endocrinol (Lausanne) 2021;12:716533. [PMID: 34858322 DOI: 10.3389/fendo.2021.716533] [Reference Citation Analysis]
16 Antonowski T, Wiśniewski K, Podlasz P, Osowski A, Wojtkiewicz J. Study of the Potential Hepatoprotective Effect of Myo-Inositol and Its Influence on Zebrafish Development. Nutrients 2021;13:3346. [PMID: 34684347 DOI: 10.3390/nu13103346] [Reference Citation Analysis]
17 Cataldi M, Manco F, Tarantino G. Steatosis, Steatohepatitis and Cancer Immunotherapy: An Intricate Story. Int J Mol Sci 2021;22:12947. [PMID: 34884762 DOI: 10.3390/ijms222312947] [Reference Citation Analysis]
18 Prasoppokakorn T, Chan WK, Wong VWS, Pitisuttithum P, Mahadeva S, Nik Mustapha NR, Wong GLH, Leung HHW, Sripongpun P, Treeprasertsuk S. Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease . World J Gastroenterol 2022; 28(15): 1563-1573 [DOI: 10.3748/wjg.v28.i15.1563] [Reference Citation Analysis]
19 Zhou J, Chen Y, Yu J, Li T, Lu Z, Chen Y, Zhang X, Ye F. The efficacy of novel metabolic targeted agents and natural plant drugs for nonalcoholic fatty liver disease treatment: A PRISMA-compliant network meta-analysis of randomized controlled trials. Medicine (Baltimore) 2021;100:e24884. [PMID: 33761646 DOI: 10.1097/MD.0000000000024884] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Lu Y, Shao M, Xiang H, Wang J, Ji G, Wu T. Qinggan Huoxue Recipe Alleviates Alcoholic Liver Injury by Suppressing Endoplasmic Reticulum Stress Through LXR-LPCAT3. Front Pharmacol 2022;13:824185. [DOI: 10.3389/fphar.2022.824185] [Reference Citation Analysis]
21 Zeng J, Qin L, Jin Q, Yang R, Ning G, Su Q, Yang Z, Fan J. Prevalence and characteristics of MAFLD in Chinese adults aged 40 years or older: A community-based study. Hepatobiliary & Pancreatic Diseases International 2022. [DOI: 10.1016/j.hbpd.2022.01.006] [Reference Citation Analysis]
22 Zhang P, Wang W, Mao M, Gao R, Shi W, Li D, Calderone R, Sui B, Tian X, Meng X. Similarities and Differences: A Comparative Review of the Molecular Mechanisms and Effectors of NAFLD and AFLD. Front Physiol 2021;12:710285. [PMID: 34393826 DOI: 10.3389/fphys.2021.710285] [Reference Citation Analysis]
23 Yang S, Li D, Yu Z, Li Y, Wu M. Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota. Front Pharmacol 2021;12:709629. [PMID: 34305616 DOI: 10.3389/fphar.2021.709629] [Reference Citation Analysis]
24 Lackovic M, Filimonovic D, Mihajlovic S, Milicic B, Filipovic I, Rovcanin M, Dimitrijevic D, Nikolic D. The Influence of Increased Prepregnancy Body Mass Index and Excessive Gestational Weight Gain on Pregnancy Course and Fetal and Maternal Perinatal Outcomes. Healthcare (Basel) 2020;8:E362. [PMID: 32987862 DOI: 10.3390/healthcare8040362] [Reference Citation Analysis]
25 Wu C, Yu P, Sun R. Adipose tissue and age‑dependent insulin resistance: New insights into WAT browning (Review). Int J Mol Med 2021;47:71. [PMID: 33693956 DOI: 10.3892/ijmm.2021.4904] [Reference Citation Analysis]
26 Ibrahim SA, Mohamed MZ, El-Tahawy NF, Abdelrahman AM. Antifibrotic effects of bezafibrate and pioglitazone against thioacetamide-induced liver fibrosis in albino rats. Can J Physiol Pharmacol 2021;99:313-20. [PMID: 32721217 DOI: 10.1139/cjpp-2020-0159] [Reference Citation Analysis]
27 Liu H, Man K. New Insights in Mechanisms and Therapeutics for Short- and Long-Term Impacts of Hepatic Ischemia Reperfusion Injury Post Liver Transplantation. Int J Mol Sci 2021;22:8210. [PMID: 34360975 DOI: 10.3390/ijms22158210] [Reference Citation Analysis]
28 Milaciu MV, Ciumărnean L, Matei DM, Vesa ȘC, Sabin O, Bocșan IC, Pop RM, Negrean V, Buzoianu AD, Acalovschi M. Cytokines, paraoxonase-1, periostin and non-invasive liver fibrosis scores in patients with non-alcoholic fatty liver disease and persistently elevated aminotransferases: A pilot study. Exp Ther Med 2021;21:533. [PMID: 33815606 DOI: 10.3892/etm.2021.9965] [Reference Citation Analysis]
29 Wang M, Zhang R, Wang M, Zhang L, Ding Y, Tang Z, Wang H, Zhang W, Chen Y, Wang J. Genetic Polymorphism of Vitamin D Family Genes CYP2R1, CYP24A1, and CYP27B1 Are Associated With a High Risk of Non-alcoholic Fatty Liver Disease: A Case-Control Study. Front Genet 2021;12:717533. [PMID: 34484304 DOI: 10.3389/fgene.2021.717533] [Reference Citation Analysis]
30 Rao A, Clayton P, Briskey D. The effect of an orally-dosed Gynostemma pentaphyllum extract (ActivAMP®) on body composition in overweight, adult men and women: A double-blind, randomised, placebo-controlled study. J Hum Nutr Diet 2021. [PMID: 34323337 DOI: 10.1111/jhn.12936] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Li Y, Liu Y, Yang M, Wang Q, Zheng Y, Xu J, Zheng P, Song H. A Study on the Therapeutic Efficacy of San Zi Yang Qin Decoction for Non-Alcoholic Fatty Liver Disease and the Underlying Mechanism Based on Network Pharmacology. Evid Based Complement Alternat Med 2021;2021:8819245. [PMID: 33505505 DOI: 10.1155/2021/8819245] [Reference Citation Analysis]
32 Rau M, Geier A. An update on drug development for the treatment of nonalcoholic fatty liver disease - from ongoing clinical trials to future therapy.Expert Rev Clin Pharmacol. 2021;14:333-340. [PMID: 33535836 DOI: 10.1080/17512433.2021.1884068] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
33 Skrzypczak D, Skrzypczak-Zielińska M, Ratajczak AE, Szymczak-Tomczak A, Eder P, Słomski R, Dobrowolska A, Krela-Kaźmierczak I. Myostatin and Follistatin-New Kids on the Block in the Diagnosis of Sarcopenia in IBD and Possible Therapeutic Implications. Biomedicines 2021;9:1301. [PMID: 34680417 DOI: 10.3390/biomedicines9101301] [Reference Citation Analysis]
34 Schiavo L, Calabrese P, Aliberti SM, Tramontano S, Iannelli A, Pilone V. Impact of SARS-CoV-2 Lockdown on the Preoperative Care Program of Patients Scheduled for Bariatric Surgery. Nutrients 2022;14:1488. [DOI: 10.3390/nu14071488] [Reference Citation Analysis]
35 Tarantino G. NAFLD or MAFLD: That is the conundrum. Hepatobiliary & Pancreatic Diseases International 2022. [DOI: 10.1016/j.hbpd.2022.01.008] [Reference Citation Analysis]
36 Tilinca MC, Tiuca RA, Niculas C, Varga A, Tilea I. Future perspectives in diabesity treatment: Semaglutide, a glucagon-like peptide 1 receptor agonist (Review). Exp Ther Med 2021;22:1167. [PMID: 34504612 DOI: 10.3892/etm.2021.10601] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Zhang J, Ren Y, Bi J, Wang M, Zhang L, Wang T, Wei S, Mou X, Lv Y, Wu R. Involvement of kindlin-2 in irisin's protection against ischaemia reperfusion-induced liver injury in high-fat diet-fed mice. J Cell Mol Med 2020;24:13081-92. [PMID: 32954626 DOI: 10.1111/jcmm.15910] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
38 Baumann A, Nier A, Hernández-Arriaga A, Brandt A, Lorenzo Pisarello MJ, Jin CJ, Pilar E, Camarinha-Silva A, Schattenberg JM, Bergheim I. Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease. Sci Rep 2021;11:17815. [PMID: 34497333 DOI: 10.1038/s41598-021-97346-9] [Reference Citation Analysis]
39 He M, Deng M, Wang J, Fan P, Wang Y, Zhao X, He Y, Shi B, Sui J. Efficacy and tolerability of sitagliptin and metformin compared with insulin as an initial therapy for newly diagnosed diabetic patients with severe hyperglycaemia. Exp Ther Med 2021;21:217. [PMID: 33574913 DOI: 10.3892/etm.2021.9649] [Reference Citation Analysis]
40 Pastor CM, Vilgrain V. Steatosis Alters the Activity of Hepatocyte Membrane Transporters in Obese Rats. Cells 2021;10:2733. [PMID: 34685713 DOI: 10.3390/cells10102733] [Reference Citation Analysis]
41 Ma D, Zeng J, Huang B, Yan F, Ye J, Chen Y, Zeng X, Zheng X, Xiao F, Lin M, Liu C, Li Z. Independent associations of thyroid-related hormones with hepatic steatosis and insulin resistance in euthyroid overweight/obese Chinese adults. BMC Gastroenterol 2021;21:431. [PMID: 34794374 DOI: 10.1186/s12876-021-02011-0] [Reference Citation Analysis]
42 Yang H, Li Q, Zhang L, Zhu M, Niu J, Xue F, Yang L, Qu Q, Lao Y, Ding Z, Xiao C, Wang K. LncPRYP4-3 serves as a novel diagnostic biomarker for dissecting subtypes of metabolic associated fatty liver disease by targeting RPS4Y2. Clin Exp Med 2020;20:587-600. [PMID: 32494880 DOI: 10.1007/s10238-020-00636-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Kositamongkol C, Kanchanasurakit S, Auttamalang C, Inchai N, Kabkaew T, Kitpark S, Chaiyakunapruk N, Duangjai A, Saokaew S, Phisalprapa P. Coffee Consumption and Non-alcoholic Fatty Liver Disease: An Umbrella Review and a Systematic Review and Meta-analysis. Front Pharmacol 2021;12:786596. [PMID: 34966282 DOI: 10.3389/fphar.2021.786596] [Reference Citation Analysis]
44 Karimi-Sales E, Mohaddes G, Alipour MR. Hepatoprotection of capsaicin in alcoholic and non-alcoholic fatty liver diseases. Arch Physiol Biochem 2021;:1-11. [PMID: 34396890 DOI: 10.1080/13813455.2021.1962913] [Reference Citation Analysis]
45 Rodriguez LA, Kanaya AM, Shiboski SC, Fernandez A, Herrington D, Ding J, Bradshaw PT. Does NAFLD mediate the relationship between obesity and type 2 diabetes risk? evidence from the multi-ethnic study of atherosclerosis (MESA). Ann Epidemiol 2021;63:15-21. [PMID: 34293421 DOI: 10.1016/j.annepidem.2021.07.005] [Reference Citation Analysis]
46 Meroni M, Longo M, Paolini E, Alisi A, Miele L, De Caro ER, Pisano G, Maggioni M, Soardo G, Valenti LV, Fracanzani AL, Dongiovanni P. The rs599839 A>G Variant Disentangles Cardiovascular Risk and Hepatocellular Carcinoma in NAFLD Patients. Cancers (Basel) 2021;13:1783. [PMID: 33917919 DOI: 10.3390/cancers13081783] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Tarantino G, Balsano C, Santini SJ, Brienza G, Clemente I, Cosimini B, Sinatti G. It Is High Time Physicians Thought of Natural Products for Alleviating NAFLD. Is There Sufficient Evidence to Use Them? Int J Mol Sci 2021;22:13424. [PMID: 34948230 DOI: 10.3390/ijms222413424] [Reference Citation Analysis]
48 Ramchoun M, Khouya T, Alibrahim EA, Hmidani A, Sellam K, Amrani S, Harnafi H, Benlyas M, Kasbi Chadli F, Ouguerram K, Alem C. Thymus atlanticus polyphenol-rich extract regulates cholesterol metabolism by inhibiting its biosynthesis without affecting its excretion in hamsters fed a high-fat diet. Arch Physiol Biochem 2020;:1-8. [PMID: 33320714 DOI: 10.1080/13813455.2020.1854308] [Reference Citation Analysis]
49 Um YJ, Chang Y, Jung HS, Cho IY, Shin JH, Shin H, Wild SH, Byrne CD, Ryu S. Sleep Duration, Sleep Quality, and the Development of Nonalcoholic Fatty Liver Disease: A Cohort Study. Clin Transl Gastroenterol 2021;12:e00417. [PMID: 34665792 DOI: 10.14309/ctg.0000000000000417] [Reference Citation Analysis]
50 Mertens J, De Block C, Spinhoven M, Driessen A, Francque SM, Kwanten WJ. Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic Hepatopathy. Front Pharmacol 2021;12:768576. [PMID: 34759828 DOI: 10.3389/fphar.2021.768576] [Reference Citation Analysis]
51 Jarvis H, O'Keefe H, Craig D, Stow D, Hanratty B, Anstee QM. Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis. BMJ Open 2022;12:e049767. [PMID: 34983755 DOI: 10.1136/bmjopen-2021-049767] [Reference Citation Analysis]
52 Wang X, Xie Z, Lou Z, Chen Y, Huang S, Ren Y, Weng G, Zhang S. Regulation of the PTEN/PI3K/AKT pathway in RCC using the active compounds of natural products in vitro. Mol Med Rep 2021;24:766. [PMID: 34490473 DOI: 10.3892/mmr.2021.12406] [Reference Citation Analysis]
53 Al-Shaebi F, Wenzhang L, Hezam K, Almezgagi M, Wei L. Recent insights of the role and signalling pathways of interleukin-34 in liver diseases. Int Immunopharmacol 2020;89:107023. [PMID: 33129098 DOI: 10.1016/j.intimp.2020.107023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Ding L, De Munck TJI, Oligschlaeger Y, Verbeek J, Koek GH, Houben T, Shiri-Sverdlov R. Insulin resistance is positively associated with plasma cathepsin D activity in NAFLD patients. Biomol Concepts 2021;12:110-5. [PMID: 34370929 DOI: 10.1515/bmc-2021-0011] [Reference Citation Analysis]
55 Rashu EB, Werge MP, Hetland LE, Junker AE, Jensen MK, Gluud LL. Referral Patterns for Patients with Nonalcoholic Fatty Liver Disease. J Clin Med 2021;10:404. [PMID: 33494361 DOI: 10.3390/jcm10030404] [Reference Citation Analysis]
56 Oh JH, Lee JH, Cho MS, Kim H, Chun J, Lee JH, Yoon Y, Kang W. Characterization of Gut Microbiome in Korean Patients with Metabolic Associated Fatty Liver Disease. Nutrients 2021;13:1013. [PMID: 33801023 DOI: 10.3390/nu13031013] [Reference Citation Analysis]
57 Wang J, He W, Tsai PJ, Chen PH, Ye M, Guo J, Su Z. Mutual interaction between endoplasmic reticulum and mitochondria in nonalcoholic fatty liver disease. Lipids Health Dis 2020;19:72. [PMID: 32284046 DOI: 10.1186/s12944-020-01210-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 13.0] [Reference Citation Analysis]
58 Lonardo A. Back to the future: From the history of NAFLD to MAFLD to heterogeneity of disease. Clinical and Translational Dis 2021;1. [DOI: 10.1002/ctd2.9] [Reference Citation Analysis]
59 Abdelnour SA, El-ratel IT, Peris SI, El-raghi AA, Fouda SF. Effects of dietary thyme essential oil on blood haematobiochemical, redox status, immunological and reproductive variables of rabbit does exposed to high environmental temperature. Italian Journal of Animal Science 2022;21:51-61. [DOI: 10.1080/1828051x.2021.2006807] [Reference Citation Analysis]
60 Zhang Y, Tan SL, Du J, Chen Y, Jia J, Feng JG, Liu KX, Zhou J. Dexmedetomidine alleviates neuroinflammation, restores sleep disorders and neurobehavioral abnormalities in rats with minimal hepatic encephalopathy. Int Immunopharmacol 2021;96:107795. [PMID: 34162157 DOI: 10.1016/j.intimp.2021.107795] [Reference Citation Analysis]
61 Lu Y, Hu L, Song J, Wan J, Chen H, Yin J. Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study. BMC Endocr Disord 2021;21:231. [PMID: 34794397 DOI: 10.1186/s12902-021-00899-z] [Reference Citation Analysis]
62 Irene GR, César M, Fernando C, Ana C. SR-B1, a Key Receptor Involved in the Progression of Cardiovascular Disease: A Perspective from Mice and Human Genetic Studies. Biomedicines 2021;9:612. [PMID: 34072125 DOI: 10.3390/biomedicines9060612] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
63 Mao Y, Hong KH, Liao W, Li L, Kim SJ, Xiong Y, Nam IK, Choe SK, Kwak SA. Generation of a Novel Transgenic Zebrafish for Studying Adipocyte Development and Metabolic Control. Int J Mol Sci 2021;22:3994. [PMID: 33924375 DOI: 10.3390/ijms22083994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Kanawati GM, Al-khateeb IH, Kandil YI. Arctigenin attenuates CCl4-induced hepatotoxicity through suppressing matrix metalloproteinase-2 and oxidative stress. Egypt Liver Journal 2021;11. [DOI: 10.1186/s43066-020-00072-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Takayama S, Katada K, Takagi T, Iida T, Ueda T, Mizushima K, Higashimura Y, Morita M, Okayama T, Kamada K, Uchiyama K, Handa O, Ishikawa T, Yasukawa Z, Okubo T, Itoh Y, Naito Y. Partially hydrolyzed guar gum attenuates non-alcoholic fatty liver disease in mice through the gut-liver axis. World J Gastroenterol 2021; 27(18): 2160-2176 [PMID: 34025071 DOI: 10.3748/wjg.v27.i18.2160] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
66 Alwehaidah MS, Al-Kafaji G, Bakhiet M, Alfadhli S. Next-generation sequencing of the whole mitochondrial genome identifies novel and common variants in patients with psoriasis, type 2 diabetes mellitus and psoriasis with comorbid type 2 diabetes mellitus. Biomed Rep 2021;14:41. [PMID: 33728047 DOI: 10.3892/br.2021.1417] [Reference Citation Analysis]
67 Huang YP, Zhang S, Zhang M, Wang Y, Wang WH, Li J, Li C, Lin JN. Gender-specific prevalence of metabolic-associated fatty liver disease among government employees in Tianjin, China: a cross-sectional study. BMJ Open 2021;11:e056260. [PMID: 34911725 DOI: 10.1136/bmjopen-2021-056260] [Reference Citation Analysis]
68 Alvarez CS, Rivera‐andrade A, Kroker‐lobos MF, Florio AA, Smith JW, Egner PA, Freedman ND, Lazo M, Guallar E, Dean M, Graubard BI, Ramírez‐zea M, Mcglynn KA, Groopman JD. Associations between aflatoxin B 1 ‐albumin adduct levels with metabolic conditions in Guatemala: A cross‐sectional study. Health Science Reports 2022;5. [DOI: 10.1002/hsr2.495] [Reference Citation Analysis]
69 Li D, Cui Y, Wang X, Liu F, Li X. Apple Polyphenol Extract Improves High-Fat Diet-Induced Hepatic Steatosis by Regulating Bile Acid Synthesis and Gut Microbiota in C57BL/6 Male Mice. J Agric Food Chem 2021;69:6829-41. [PMID: 34124904 DOI: 10.1021/acs.jafc.1c02532] [Reference Citation Analysis]
70 Tarantino G, Citro V, Balsano C. Liver-spleen axis in nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol 2021;15:759-69. [PMID: 33878988 DOI: 10.1080/17474124.2021.1914587] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Holzner LMW, Murray AJ. Hypoxia-Inducible Factors as Key Players in the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis. Front Med (Lausanne) 2021;8:753268. [PMID: 34692739 DOI: 10.3389/fmed.2021.753268] [Reference Citation Analysis]
72 Kolnes KJ, Petersen MH, Lien-Iversen T, Højlund K, Jensen J. Effect of Exercise Training on Fat Loss-Energetic Perspectives and the Role of Improved Adipose Tissue Function and Body Fat Distribution. Front Physiol 2021;12:737709. [PMID: 34630157 DOI: 10.3389/fphys.2021.737709] [Reference Citation Analysis]
73 Lee HS, In S, Park T. The Homocysteine and Metabolic Syndrome: A Mendelian Randomization Study. Nutrients 2021;13:2440. [PMID: 34371949 DOI: 10.3390/nu13072440] [Reference Citation Analysis]
74 Suo LG, Qin RX, Cui YY, Qin XJ. Decreased expression of TIPE2 in the eye under high-glucose conditions tested in vivo and in vitro. Int Immunopharmacol 2021;95:107517. [PMID: 33725633 DOI: 10.1016/j.intimp.2021.107517] [Reference Citation Analysis]
75 Bhave S, Ho HK. Exploring the Gamut of Receptor Tyrosine Kinases for Their Promise in the Management of Non-Alcoholic Fatty Liver Disease. Biomedicines 2021;9:1776. [PMID: 34944593 DOI: 10.3390/biomedicines9121776] [Reference Citation Analysis]
76 Baradaran Ghavami S, Asadzadeh Aghdaei H, Sorrentino D, Shahrokh S, Farmani M, Ashrafian F, Dore MP, Keshavarz Azizi Raftar S, Mobin Khoramjoo S, Zali MR. Probiotic-Induced Tolerogenic Dendritic Cells: A Novel Therapy for Inflammatory Bowel Disease? Int J Mol Sci 2021;22:8274. [PMID: 34361038 DOI: 10.3390/ijms22158274] [Reference Citation Analysis]
77 Luo H, Xu N, Wu J, Gan Y, Chen L, Guan F, Li M, Li Y, Chen J, Su Z, Liu Y. β-patchoulene protects against non-alcoholic steatohepatitis via interrupting the vicious circle among oxidative stress, histanoxia and lipid accumulation in rats. Int Immunopharmacol 2021;98:107915. [PMID: 34198236 DOI: 10.1016/j.intimp.2021.107915] [Reference Citation Analysis]
78 Souza CO, Teixeira AAS, Biondo LA, Silveira LS, de Souza Breda CN, Braga TT, Camara NOS, Belchior T, Festuccia WT, Diniz TA, Ferreira GM, Hirata MH, Chaves-Filho AB, Yoshinaga MY, Miyamoto S, Calder PC, Sethi JK, Rosa Neto JC. Palmitoleic acid reduces high fat diet-induced liver inflammation by promoting PPAR-γ-independent M2a polarization of myeloid cells. Biochim Biophys Acta Mol Cell Biol Lipids 2020;1865:158776. [PMID: 32738301 DOI: 10.1016/j.bbalip.2020.158776] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
79 Wang J, Su Z, Feng Y, Xi R, Liu J, Wang P. Comparison of several blood lipid-related indexes in the screening of non-alcoholic fatty liver disease in women: a cross-sectional study in the Pearl River Delta region of southern China. BMC Gastroenterol 2021;21:482. [PMID: 34923965 DOI: 10.1186/s12876-021-02072-1] [Reference Citation Analysis]
80 Kautzky A, Heneis K, Stengg K, Fröhlich S, Kautzky-Willer A. Short Term Caloric Restriction and Biofeedback Enhance Psychological Wellbeing and Reduce Overweight in Healthy Women. J Pers Med 2021;11:1096. [PMID: 34834448 DOI: 10.3390/jpm11111096] [Reference Citation Analysis]
81 Taherkhani S, Suzuki K, Ruhee RT. A Brief Overview of Oxidative Stress in Adipose Tissue with a Therapeutic Approach to Taking Antioxidant Supplements. Antioxidants (Basel) 2021;10:594. [PMID: 33924341 DOI: 10.3390/antiox10040594] [Cited by in F6Publishing: 2] [Reference Citation Analysis]